Erik Pacyniak
- Virology top 2%
- HIV Research and Treatment 17
-
- Toxic Organic Pollutants Impact 3
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment 10
- HIV/AIDS Research and Interventions 2
-
- Herpesvirus Infections and Treatments 4
- Cytomegalovirus and herpesvirus research 4
-
- Drug Transport and Resistance Mechanisms 3
-
- Carcinogens and Genotoxicity Assessment 2
- Co-authors
- Edward B. StephensGrace L. GuoDavid R. HoutCurtis D. KlaassenMichael L. CunninghamXingguo ChengKevin M. CroftonDavid M. Pinson
- Journals
- Virology (10 papers)Journal of Pharmaceutical Sciences (1 paper)Toxicology and Applied Pharmacology (1 paper)
- Partner nations
- United StatesCameroon
In The Last Decade
Erik Pacyniak
23 papers receiving 596 citations
Peers
Comparison fields: 5 of 81
- Virology 330
- Health, Toxicology and Mutagenesis 127
- Infectious Diseases 158
- Immunology 107
- Epidemiology 147
Countries citing papers authored by Erik Pacyniak
This map shows the geographic impact of Erik Pacyniak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Pacyniak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Pacyniak more than expected).
Fields of papers citing papers by Erik Pacyniak
This network shows the impact of papers produced by Erik Pacyniak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Pacyniak. The network helps show where Erik Pacyniak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Erik Pacyniak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 13 | |
| 2 | 2015 | 18 | |
| 3 | 2013 | 16 | |
| 4 | 2011 | 8 | |
| 5 | 2010 | 36 | |
| 6 | 2007 | 20 | |
| 7 | 2007 | 123 | |
| 8 | 2006 | 15 | |
| 9 | 2006 | 31 | |
| 10 | 2005 | 52 | |
| 11 | 2005 | 36 | |
| 12 | 2005 | 31 | |
| 13 | 2004 | 4 | |
| 14 | 2003 | 14 | |
| 15 | 2003 | 29 | |
| 16 | 2003 | 2 | |
| 17 | 2002 | 55 | |
| 18 | 2002 | 18 | |
| 19 | 2001 | 11 | |
| 20 | 2001 | 22 |
About Erik Pacyniak
Erik Pacyniak is a scholar working on Virology, Chemical Health and Safety and Infectious Diseases, having authored 23 papers that have together received 600 indexed citations. Recurring topics across this work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (10 papers), Herpesvirus Infections and Treatments (4 papers), Cytomegalovirus and herpesvirus research (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Toxic Organic Pollutants Impact (3 papers), HIV/AIDS Research and Interventions (2 papers) and Carcinogens and Genotoxicity Assessment (2 papers). The work is most often cited by research in Virology (330 citations), Health, Toxicology and Mutagenesis (127 citations) and Infectious Diseases (158 citations). Erik Pacyniak has collaborated with scholars based in United States and Cameroon. Frequent co-authors include Edward B. Stephens, Grace L. Guo, David R. Hout, Curtis D. Klaassen, Michael L. Cunningham, Xingguo Cheng, Kevin M. Crofton, David M. Pinson, Dinesh Kumar Singh and Scott W. Wong. Their work appears in journals such as Virology, Journal of Pharmaceutical Sciences and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.